Diagnosing latent tuberculosis infection in patients with psoriasis under antitumour necrosis factor-α treatment: every new solution breeds new doubts

Comment

A I Sánchez-Moya et al. Br J Dermatol. 2011 Jan.

. 2011 Jan;164(1):208-9.

doi: 10.1111/j.1365-2133.2010.10028.x. Epub 2010 Nov 4.

No abstract available

Comment on

Tuberculosis and tumour necrosis factor-alpha inhibitor therapy: a report of three cases in patients with psoriasis. Comprehensive screening and therapeutic guidelines for clinicians.
Perlmutter A, Mittal A, Menter A. Perlmutter A, et al. Br J Dermatol. 2009 Jan;160(1):8-15. doi: 10.1111/j.1365-2133.2008.08891.x. Epub 2008 Oct 22. Br J Dermatol. 2009. PMID: 19016693 Review.
Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test.
Laffitte E, Janssens JP, Roux-Lombard P, Thielen AM, Barde C, Marazza G, Panizzon RG, Saurat JH. Laffitte E, et al. Br J Dermatol. 2009 Oct;161(4):797-800. doi: 10.1111/j.1365-2133.2009.09331.x. Epub 2009 Jun 5. Br J Dermatol. 2009. PMID: 19659473
British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009.
Smith CH, Anstey AV, Barker JN, Burden AD, Chalmers RJ, Chandler DA, Finlay AY, Griffiths CE, Jackson K, McHugh NJ, McKenna KE, Reynolds NJ, Ormerod AD; (Chair of Guideline Group). Smith CH, et al. Br J Dermatol. 2009 Nov;161(5):987-1019. doi: 10.1111/j.1365-2133.2009.09505.x. Br J Dermatol. 2009. PMID: 19857207 No abstract available.